- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01998282
Evaluation of a Project to Distribute Water Filters and Cook Stoves in Western Rwanda--Phase 1B
March 9, 2017 updated by: Thomas Clasen, London School of Hygiene and Tropical Medicine
Assessing the Impact of Water Filters and Improved Cook Stoves on Drinking Water and Quality and Indoor Air Pollution: A Matched Cohort Study in Rwanda
DelAgua Health and Development, Manna Energy and the Rwanda Ministry of Health are collaborating on a project financed by carbon credits that will distribute household-based water filters and high-efficiency cook stoves to approximately 600,000 households in Rwanda.
Prior to the full roll out of the campaign, the implementers are conducting research in connection with a distribution among 2000 households in western Rwanda.
The objective of this matched cohort study (Phase 1B)are to investigate whether the filters and stoves delivered in October 2012 are still performing and in use, to determine whether they are associated with reductions in exposure to pathogens from drinking water and stoves, and to assembly information on health and other conditions necessary for the design of a large scale health impact evaluation.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
1035
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
PO Box 1594
-
Kigali, PO Box 1594, Rwanda
- DelAgua Health Rwanda
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Lower income (ubudehe groups 1 and 2) householders from 18 villages (9 intervention and matched controls) in 11 designated Districts in Rwanda: Rutsiro, Karongi, Ngororero, Nyamasheke, Nyabihu Districts of Western Province (excluding part of the district to the north of the Ruhengeri road); Rubuvu District (excluding part of the district to the north of the Ruhengeri road); Nyaruguru, Nyamagabe, Muhanga, and Ruhango Districts in Southern Province; Gakenke District in Northern Province.
Description
Households will be eligible to participate in the study if they reside in selected villages and are willing to participate after receiving complete details regarding the study.
Intervention households must have a functioning stove and water filter in order to participate, though they do not need to be in regular use.
We will enroll all households with a child under 5 years of age if they are in Ubudehe groups 1 or 2.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
Household water filter and improved cook stove
Vestergaard-Frandsen LifeStraw Family 2.0 filter and Ecozoom stove
|
Control
Traditional water management practices and cooking stoves
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Personal exposure to PM2.5 and CO (mg/m3)
Time Frame: 10 months
|
PM2.5 and CO concentrations will be measure in mg/m3 and reported as the mean concentration over 48 hours.
|
10 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Thermotolerant coliforms (TTC) in colony forming units (CFU) per 100ml of sample water
Time Frame: 10 months
|
TTC will be measured as the total number of colony forming units (CFU) of TTC in the water sample and will be reported as number of CFU per 100ml of sample water.
|
10 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood pressure
Time Frame: 10 months
|
10 months
|
|
Blood pressure covariates
Time Frame: 10 months
|
10 months
|
|
Use of filter and stove
Time Frame: 10 months
|
10 months
|
|
Exposure to PM2.5 and CO in primary cooking areas (mg/m3)
Time Frame: 10 months
|
PM2.5 and CO concentrations during the 48 hour sampling period
|
10 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Thomas F Clasen, PhD, London School of Hygiene and Tropical Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2013
Primary Completion (Actual)
December 31, 2016
Study Completion (Actual)
December 31, 2016
Study Registration Dates
First Submitted
November 8, 2013
First Submitted That Met QC Criteria
November 23, 2013
First Posted (Estimate)
November 28, 2013
Study Record Updates
Last Update Posted (Actual)
March 13, 2017
Last Update Submitted That Met QC Criteria
March 9, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 6457
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Focus of Study is to Assess Filter and Stove Use and Efficacy in Reducing Exposure to Waterborne and Airborne Pathogens
-
Helm Vision GroupRecruitingThe Focus of the Study is to Assess the Effectiveness of Topical Ivermectin on Eliminating Eyelash SleevesUnited States
-
Lee's Pharmaceutical LimitedFidia Farmaceutici s.p.a.CompletedThe Primary Objective of This Study Was to Assess the Efficacy and Safety of Hyaluronic Acid Vaginal Gel in Treating Vaginal Dryness
-
Michigan State UniversityCompletedFocus of Study is to Determine Efficacy of CompexUnited States
-
European Institute for Evidence Based Osteopathic...AvailableThe Focus of the Study is to Provide a Guideline on Osteopathic Approach in Treating Hospitalized Newborns.
-
Jinnah Sindh Medical UniversityAl Khidmat Hospital Nazimabad Karachi; Medics Laboratories (Pvt.) Ltd.CompletedThe Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive PatientsPakistan
-
Johannes Gutenberg University MainzUnknownFocus of the Study is to Evaluate a New Developed Deep-learning Computer-aided Detection System in Combination With LCI for Colorectal Polyp DetectionGermany
-
Boston Scientific CorporationActive, not recruitingThe Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial FibrillationDenmark
-
University of IowaCompletedThe Focus of the Study is to Monitor MRI Signal Changes and Inflammatory Biomarkers With Use of Aspirin in Patients With Unruptured Cerebral AneurysmUnited States
-
University Of PerugiaUnknownThe Primary Study Objective is to Assess the Efficacy and | Safety of Extended 4-week Heparin Prophylaxis Compared to | Prophylaxis Given for 8±2 Days After Planned Laparoscopic | Surgery for Colorectal Cancer. | The Clinical Benefit Will be Evaluated as the Difference in | the Incidence of... and other conditionsItaly
-
Wuhan UniversityPeking University; PfizerUnknownThe Primary Evaluation is the Change From Baseline at End of Study for CDSS Total Scores. | The Secondary Efficacy Evaluations Include: MADRS, PANSS Total Scores and Subscales and Responder Rate; CGI-S and CGI-I Scales. | Safety Evaluations Include: Laboratory Test Abnormalities; BARS... and other conditions